These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 26668509)

  • 1. Clinicopathological characteristics of clinical early gastric cancer in the upper-third stomach.
    Ichikawa D; Komatsu S; Kosuga T; Konishi H; Okamoto K; Shiozaki A; Fujiwara H; Otsuji E
    World J Gastroenterol; 2015 Dec; 21(45):12851-6. PubMed ID: 26668509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
    Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
    Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
    Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
    PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes after radical gastrectomy in gastric cancer patients with overt bleeding.
    Wang L; Wang XA; Hao JQ; Zhang LN; Li ML; Wu XS; Weng H; Lv WJ; Zhang WJ; Chen L; Xiang HG; Lu JH; Liu YB; Dong P
    World J Gastroenterol; 2015 Dec; 21(47):13316-24. PubMed ID: 26715815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic differences between early gastric remnant cancer and early primary gastric cancer in the upper third of the stomach.
    Imada T; Rino Y; Hatori S; Shiozawa M; Takahashi M; Amano T; Kondo J; Kobayashi O; Sairenji M; Motohashi H
    Hepatogastroenterology; 2000; 47(34):1186-8. PubMed ID: 11020911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastasis in gastric cancer in the upper third of the stomach--surgical treatment on the basis of the anatomical distribution of positive node.
    Kitamura K; Nishida S; Yamamoto K; Ichikawa D; Okamoto K; Taniguchi H; Yamaguchi T; Sawai K; Takahashi T
    Hepatogastroenterology; 1998; 45(19):281-5. PubMed ID: 9496527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary study on pre-operative tumor volumetry measured by three-dimensional computer tomography in gastric cancer.
    Kikuchi S; Mieno H; Moriya H; Hosoda K; Yamashita K; Watanabe M; Kubota K; Matsunaga K
    Hepatogastroenterology; 2015; 62(137):214-8. PubMed ID: 25911898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of clinicopathological characteristics and prognosis of patients with gastric cancer in different locations after radical resection].
    Liu XY; Liang H; Deng JY; Pan Y; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Mar; 13(3):181-4. PubMed ID: 20336534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal extent of lymph node dissection for T1 gastric cancer, with special reference to the distribution of micrometastasis, and accuracy of preoperative diagnosis for wall invasion.
    Kojima N; Yonemura Y; Bando E; Morimoto K; Kawamura T; Yun HY; Ito I; Kameya T; Hayashi I
    Hepatogastroenterology; 2008; 55(84):1112-7. PubMed ID: 18705341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early gastric cancer: a single-institution experience on 60 cases.
    Sigon R; Canzonieri V; Rossi C
    Suppl Tumori; 2003; 2(5):S23-6. PubMed ID: 12914385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological mixed-type as an independent prognostic factor in stage I gastric carcinoma.
    Komatsu S; Ichikawa D; Miyamae M; Shimizu H; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Kishimoto M; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(2):549-55. PubMed ID: 25593472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better prognosis of T2 gastric cancer with preoperative diagnosis of early gastric cancer.
    Tokunaga M; Hiki N; Fukunaga T; Ohyama S; Yamada K; Yamaguchi T
    Ann Surg Oncol; 2009 Jun; 16(6):1514-9. PubMed ID: 19290492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective analysis of extended gastrectomy and lymphadenectomy in early gastric cancer patients].
    Huang BJ; Lu C; Xu HM; Xu YY; Chen JQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):221-5. PubMed ID: 17520378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features and outcome of surgical treatment of 149 patients with early (pT1) gastric cancer.
    Skoropad V; Berdov B; Zagrebin V
    Onkologie; 2005 May; 28(5):247-52. PubMed ID: 15867480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal of the surgical options for primary tumor control during sentinel node navigation surgery based on the discrepancy between preoperative and postoperative early gastric cancer diagnoses.
    Park JY; Ryu KW; Eom BW; Yoon HM; Kim SJ; Cho SJ; Lee JY; Kim CG; Kook MC; Choi IJ; Nam BH; Kim YW
    Ann Surg Oncol; 2014 Apr; 21(4):1123-9. PubMed ID: 24366418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric Remnant Cancer: Continuing Serious and Insidious Problem for Surgeons.
    Oymaci E; Sari E; Uçar AD; Erkan N; Yildirim M
    Hepatogastroenterology; 2015 May; 62(139):727-31. PubMed ID: 26897962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.